MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases

Free Radical Biology and Medicine

Volumn 64, Issue , 2013, Pages 31-39

  Aranda, Juan F ^a   Madrigal Matute, Julio ^a   Rotllan, Noemi ^a   Fernández Hernando, Carlos ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Free radicals; Lipid metabolism; MiRNAs

Indexed keywords

ABC TRANSPORTER A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MICRORNA; MICRORNA 1; MICRORNA 122; MICRORNA 206; MICRORNA 27A; MICRORNA 27B; MICRORNA 33; MICRORNA 33 ANTIBODY; MICRORNA 378; PROTEINASE; REACTIVE OXYGEN METABOLITE; RNA ANTIBODY; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR GENE THERAPY; CELL ACTIVATION; CHOLESTEROL METABOLISM; ENDOTHELIUM CELL; HUMAN; IRON METABOLISM; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MODULATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; FREE RADICALS; LIPID METABOLISM; MIRNAS;

ATHEROSCLEROSIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; METABOLIC SYNDROME X; MICRORNAS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84885184011     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.07.014     Document Type: Review

References (105)

1. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233; 2009.
2. Voinnet, O. Origin, biogenesis, and activity of plant microRNAs. Cell 136:669-687; 2009.
3. Krol, J.; Loedige, I.; Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11: 597-610; 2010.
4. Carthew, R. W.; Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655; 2009.
5. Heimberg, A. M.; Sempere, L. F.; Moy, V. N.; Donoghue, P. C.; Peterson, K. J. MicroRNAs and the advent of vertebrate morphological complexity. Proc. Natl. Acad. Sci. USA 105:2946-2950; 2008. (Pubitemid 351727919)
6. Gregory, R. I.; Yan, K. P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N., et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 432:235-240; 2004. (Pubitemid 39545855)
7. Davis, N.; Mor, E.; Ashery-Padan, R. Roles for Dicer1 in the patterning and differentiation of the optic cup neuroepithelium. Development 138:127-138; 2011.
8. Zhang, H.; Kolb, F. A.; Brondani, V.; Billy, E.; Filipowicz, W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J. 21:5875-5885; 2002. (Pubitemid 35315285)
9. Esteller, M. Non-coding RNAs in human disease. Nat. Rev. Genet. 12:861-874; 2011.
10. Fernandez, C.; Lobo, M. M. V.; Gomez-Coronado, D.; Lasuncion, M. A. Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation. Exp. Cell Res. 300:109-120; 2004. (Pubitemid 39286221)
11. Fernandez, C.; Martin, M.; Gomez-Coronado, D.; Lasuncion, M. A. Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression. J. Lipid Res. 46:920-929; 2005.
12. Lopez, A. D.; Mathers, C. D.; Ezzati, M.; Jamison, D. T.; Murray, C. J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747-1757; 2006. (Pubitemid 43767064)
13. Lagos-Quintana, M.; Rauhut, R.; Yalcin, A.; Meyer, J.; Lendeckel, W.; Tuschl, T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735-739; 2002. (Pubitemid 34455427)
14. Chang, J.; Nicolas, E.; Marks, D.; Sander, C.; Lerro, A.; Buendia, M. A., et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 1:106-113; 2004.
15. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689; 2005.
16. Elmen, J.; Lindow, M.; Silahtaroglu, A.; Bak, M.; Christensen, M.; Lind-Thomsen, A., et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36:1153-1162; 2008. (Pubitemid 351330933)
17. Tsai, W. C.; Hsu, S. D.; Hsu, C. S.; Lai, T. C.; Chen, S. J.; Shen, R., et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122:2884-2897; 2012.
18. Hsu, S. H.; Wang, B.; Kota, J.; Yu, J.; Costinean, S.; Kutay, H., et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122:2871-2883; 2012.
19. Rayner, K.J.; Sheedy, F.J.; Esau, C. C; Hussain, F. N.; Temel, R. E.; Parathath, S. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest. 121::2921; 2011.
20. Marquart, T. J.; Allen, R. M.; Ory, D. S.; Baldan, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. USA 107:12228-12232; 2010.
21. Najafi-Shoushtari, S. H.; Kristo, F.; Li, Y.; Shioda, T.; Cohen, D. E.; Gerszten, R. E., et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328:1566-1569; 2010.
22. Horie, T.; Ono, K.; Horiguchi, M.; Nishi, H.; Nakamura, T.; Nagao, K., et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl. Acad. Sci. USA 107:17321-17326; 2010.
23. Marquart, T. J.; Wu, J.; Lusis, A. J.; Baldan, A. Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 33:455-458; 2013.
24. Li, T.; Francl, J.M.; Boehme S.; and Chiang, J.Y.; Regulation of cholesterol and bile acid homeostasis by the CYP7A1/SREBP2/miR-33a axis, Hepatology 2013, http://dx.doi.org/10.1002/hep.26427.
25. Davalos, A.; Goedeke, L.; Smibert, P.; Ramirez, C. M.; Warrier, N. P.; Andreo, U., et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. USA 108:9232-9237; 2011.
26. Gerin, I.; Clerbaux, L. A.; Haumont, O.; Lanthier, N.; Das, A. K.; Burant, C. F., et al. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J. Biol. Chem. 285:33652-33661; 2010.
27. Ramirez, C. M.; Goedeke, L.; Rotllan, N.; Yoon, J. H.; Cirera-Salinas, D.; Mattison, J. A., et al. MiR-33 regulates glucose metabolism. Mol. Cell. Biol. 33:2891-2902; 2013.
28. Goedeke, L; Vales-Lara, F. M.; Fenstermaker, M.; Cirera-Salinas, D.; Chamorro-Jorganes, A.; Ramirez, C. M., et al. A regulatory role for miRNA-33 in controlling lipid metabolism gene expression. Mol. Cell. Biol. 33:2339-2352; 2013.
29. Ho, P. C; Chang, K. C; Chuang, Y S.; Wei, L N. Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J 25:1758-1766; 2011.
30. -/-" mice. Arterioscler. Thromb. Vasc. Biol. 33; 2013. 1973-1977.
31. -/- mice. J. Am. Heart Assoc. 1:e003376; 2012.
32. Ramirez, C. M.; Davalos, A.; Goedeke, L.; Salerno, A. G.; Warrier, N.; Cirera-Salinas, D., et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol. 31:2707-2714; 2011.
33. Kim, J.; Yoon, H.; Ramirez, C. M.; Lee, S. M.; Hoe, H. S.; Fernandez-Hernando, C, et al. MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp. Neurol. 235:476-483; 2012.
34. Ramirez, C. M.; Rotllan, N.; Vlassov, A. V.; Davalos, A.; Li, M.; Goedeke, L, et al. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ. Res. 112:1592-1601; 2013.
35. de Aguiar Vallim, T. Q.; Tarling, E. J.; Kim, T.; Civelek, M.; Baldan, A.; Esau, C; Edwards, P. A. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor. Circ. Res. 112:1602-1612; 2013.
36. Acton, S.; Rigotti, A.; Landschulz, K. T.; Xu, S.; Hobbs, H. H.; Krieger, M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520; 1996.
37. Azhar, S.; Nomoto, A.; Leers-Sucheta, S.; Reaven, E. Simultaneous induction of an HDL receptor protein (SR-BI) and the selective uptake of HDL-cholesteryl esters in a physiologically relevant steroidogenic cell model. J. Lipid Res 39:1616-1628; 1998. (Pubitemid 28377926)
38. Landschulz, K. T.; Pathak, R. K.; Rigotti, A.; Krieger, M.; Hobbs, H. H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98:984-995; 1996. (Pubitemid 26293317)
39. Hu, Z.; Shen, W J.; Kraemer, F. B.; Azhar, S. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol. Cell. Biol. 32:5035-5045; 2012.
40. Wang, L; Jia, X. J.; Jiang, H. J.; Du, Y; Yang, F.; Si, S. Y, et al. MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol. Cell Biol. 33:1956-1964; 2013.
41. Zelcer, N.; Tontonoz, P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116:607-614; 2006. (Pubitemid 43326865)
42. Cha, J. Y; Repa, J. J. The liver X receptor (LXR) and hepatic lipogenesis: the carbohydrate-response element-binding protein is a target gene of LXR. J. Biol. Chem 282:743-751; 2007. (Pubitemid 47076632)
43. Zhong, D.; Huang, G.; Zhang, Y; Zeng, Y.; Xu, Z.; Zhao, Y, et al. MicroRNA-1 and microRNA-206 suppress LXRalpha-induced lipogenesis in hepatocytes. Cell. Signalling 25:1429-1437; 2013.
44. Zhong, D.; Zhang, Y; Zeng, Y. J.; Gao, M.; Wu, G. Z.; Hu, C. J., et al. MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRalpha. Lipids Health Dis. 12:32; 2013.
45. Esau, C.; Kang, X.; Peralta, E.; Hanson, E.; Marcusson, E. G.; Ravichandran, L. V., et al. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 279:52361-52365; 2004. (Pubitemid 39656612)
46. Bork, S.; Horn, P.; Castoldi, M.; Hellwig, I.; Ho, A. D.; Wagner, W. Adipogenic differentiation of human mesenchymal stromal cells is down-regulated by microRNA-369-5p and up-regulated by microRNA-371. J. Cell Physiol. 226:2226-2234; 2011.
47. Gerin, I.; Bommer, G. T.; McCoin, C. S.; Sousa, K. M.; Krishnan, V.; MacDougald, O. A. Roles for miRNA-378/378 in adipocyte gene expression and lipogenesis. Am. J. Physiol. Endocrinol. Metab. 299:E198-E206; 2010.
48. Vickers, K. C.; Shoucri, B. M.; Levin, M. G.; Wu, H.; Pearson, D. S.; Osei-Hwedieh, D., et al. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 57:533-542; 2013.
49. Lee, E. K.; Lee, M. J.; Abdelmohsen, K.; Kim, W.; Kim, M. M.; Srikantan, S., et al. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol. Cell. Biol. 31:626-638; 2011.
50. Bidzhekov, K.; Gan, L.; Denecke, B.; Rostalsky, A.; Hristov, M.; Koeppel, T. A., et al. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb. Haemostasis 107:619-625; 2012.
51. Raitoharju, E.; Lyytikainen, L. P.; Levula, M.; Oksala, N.; Mennander, A.; Tarkka, M., et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219:211-217; 2011.
52. Cipollone, F.; Felicioni, L.; Sarzani, R.; Ucchino, S.; Spigonardo, F.; Mandolini, C., et al. A unique microRNA signature associated with plaque instability in humans. Stroke 42:2556-2563; 2011.
53. Wang, S.; Wang, L.; Zhu, T.; Gao, X.; Li, J.; Wu, Y., et al. Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors. BMC Genomics 11: 163; 2010.
54. Williams, K. J.; Tabas, I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:551-561; 1995.
55. Heinecke, J. W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141:1-15; 1998. (Pubitemid 28539412)
56. Li, D.; Yang, P.; Xiong, Q.; Song, X.; Yang, X.; Liu, L., et al. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J. Hypertens. 28:1646-1654; 2010.
57. Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415; 1988. (Pubitemid 18090241)
58. Qin, B.; Xiao, B.; Liang, D.; Xia, J.; Li, Y.; Yang, H. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem. Biophys. Res. Commun. 410:127-133; 2011.
59. Qin, B.; Xiao, B.; Liang, D.; Li, Y.; Jiang, T.; Yang, H. MicroRNA let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced endothelial apoptosis. BMB Rep 45:464-469; 2012.
60. Suarez, Y.; Fernandez-Hernando, C.; Pober, J. S.; Sessa, W. C. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100:1164-1173; 2007. (Pubitemid 46684129)
61. Wu, W.; Xiao, H.; Laguna-Fernandez, A.; Villarreal Jr G.; Wang, K. C.; Geary, G. G., et al. Flow-dependent regulation of Kruppel-like factor 2 is mediated by microRNA-92a. Circulation 124:633-641; 2011.
62. Weber, M.; Baker, M. B.; Moore, J. P.; Searles, C. D. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem. Biophys. Res. Commun. 393:643-648; 2010.
63. Ito, T.; Yagi, S.; Yamakuchi, M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 398:735-740; 2010.
64. Zhao, T.; Li, J.; Chen, A. F. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 299:E110-E116; 2010.
65. Menghini, R.; Casagrande, V.; Cardellini, M.; Martelli, E.; Terrinoni, A.; Amati, F., et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524-1532; 2009.
66. Chen, Z.; Shentu, T.P.; Wen, L.; Johnson, D.A.; and Shyy, J.Y.; Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium, Antioxid. Redox Signaling, (in press).
67. Vidal, F.; Colome, C.; Martinez-Gonzalez, J.; Badimon, L. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells. Eur. J. Biochem 252:378-384; 1998. (Pubitemid 28156861)
68. Tabas, I.; Williams, K. J.; Boren, J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116: 1832-1844; 2007. (Pubitemid 350287108)
69. Ni, C. W.; Qiu, H.; Jo, H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am. J. Physiol. Heart Circ. Physiol 300:H1762-H1769; 2011.
70. Zhou, J.; Wang, K. C.; Wu, W.; Subramaniam, S.; Shyy, J. Y.; Chiu, J. J., et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc. Natl. Acad. Sci. USA 108:10355-10360; 2011.
71. Fang, Y.; Davies, P. F. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler. Thromb. Vasc. Biol. 32:979-987; 2012.
72. Chen, T.; Huang, Z.; Wang, L.; Wang, Y.; Wu, F.; Meng, S., et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc. Res. 83:131-139; 2009.
73. Yang, K.; He, Y S.; Wang, X. Q.; Lu, L; Chen, Q. J.; Liu, J., et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett. 585:854-860; 2011.
74. Thulin, P.; Wei, T.; Werngren, O.; Cheung, L; Fisher, R. M.; Grander, D., et al. MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor delta in human monocytes during the inflammatory response. Int. J. Mol. Med. 31:1003-1010; 2013.
75. Thulasingam, S.; Massilamany, C; Gangaplara, A.; Dai, H.; Yarbaeva, S.; Subramaniam, S., et al. miR-27b, an oxidative stress-responsive microRNA modulates nuclear factor-KB pathway in RAW 264.7 cells. Mol. Cell. Biochem. 352:181-188; 2011.
76. Rong, J. X.; Shapiro, M.; Trogan, E.; Fisher, E. A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. USA 100:13531-13536; 2003. (Pubitemid 37444776)
77. Lacolley, P.; Regnault, V.; Nicoletti, A.; Li, Z.; Michel, J. B. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc. Res. 95:194-204; 2012.
78. Fernandez-Ortiz, A.; Badimon, J. J.; Falk, E.; Fuster, V.; Meyer, B.; Mailhac, A., et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J. Am. Coll. Cardiol. 23:1562-1569; 1994. (Pubitemid 24182120)
79. Sun, S. G.; Zheng, B.; Han, M.; Fang, X. M.; Li, H. X.; Miao, S. B., et al. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 12:56-62; 2011.
80. Chen, W J.; Yin, K.; Zhao, G. J.; Fu, Y C; Tang, C. K. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis 222:314-323; 2012.
81. Lin, Y; Liu, X.; Cheng, Y; Yang, J.; Huo, Y; Zhang, C. Involvement of microRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J. Biol. Chem. 284:7903-7913; 2009.
82. Sawamura, T.; Kume, N.; Aoyama, T.; Moriwaki, H.; Hoshikawa, H.; Aiba, Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73-77; 1997. (Pubitemid 27130922)
83. Sun, Y; Chen, X. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species. Fundam. Clin. Pharmacol 25:572-579; 2011.
84. Ding, Z.; Wang, X.; Khaidakov, M.; Liu, S.; Mehta, J. L. MicroRNA hsa-let-7g targets lectin-like oxidized low-density lipoprotein receptor-1 expression and inhibits apoptosis in human smooth muscle cells. Exp. Biol. Med. (Maywood) 237:1093-1100; 2012.
85. Chen, K. C; Wang, Y S.; Hu, C. Y; Chang, W. C; Liao, Y. C; Dai, C. Y, et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J25:1718-1728; 2011.
86. Boon, R. A.; Seeger, T.; Heydt, S.; Fischer, A.; Hergenreider, E.; Horrevoets, A. J., et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ. Res. 109:1115-1119; 2011.
87. Chan, S. Y; Zhang, Y Y; Hemann, C; Mahoney, C. E.; Zweier, J. L; Loscalzo, J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10:273-284; 2009.
88. Favaro, E.; Ramachandran, A.; McCormick, R.; Gee, H.; Blancher, C; Crosby, M., et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and Krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 5:e10345; 2010.
89. Castoldi, M.; Vujic, S. M.; Altamura, S.; Elmen, J.; Lindow, M.; Kiss, J., et al. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J. Clin. Invest. 121:1386-1396; 2011.
90. Shan, Y; Zheng, J.; Lambrecht, R. W.; Bonkovsky, H.L. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 133:1166-1174; 2007. (Pubitemid 47494462)
91. Martin-Ventura, J. L; Madrigal-Matute, J.; Martinez-Pinna, R.; Ramos-Mozo, P.; Blanco-Colio, L M.; Moreno, J. A., et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options. Thromb. Haemostasis 108:435-442; 2012.
92. Bastida, E.; Ordinas, A.; Escolar, G.; Jamieson, G. A. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 64:177-184; 1984. (Pubitemid 14083873)
93. Chen, X.; Liang, H.; Zhang, J.; Zen, K.; Zhang, C.Y Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 22:125-132; 2012.
94. Creemers, E. E.; Tijsen, A. J.; Pinto, Y M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110:483-495; 2012.
95. Vickers, K. C; Palmisano, B. T.; Shoucri, B. M.; Shamburek, R. D.; Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13:423-433; 2011.
96. Arroyo, J. D.; Chevillet, J. R.; Kroh, E. M.; Ruf, I. K.; Pritchard, C. C; Gibson, D. F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 108:5003-5008; 2011.
97. Fichtlscherer, S.; De, R. S.; Fox, H.; Schwietz, T.; Fischer, A.; Liebetrau, C., et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107:677-684; 2010.
98. Tan, K. S.; Armugam, A.; Sepramaniam, S.; Lim, K. Y.; Setyowati, K. D.; Wang, C. W., et al. Expression profile of microRNAs in young stroke patients. PLoS One 4:e7689; 2009.
99. Fichtlscherer, S.; Zeiher, A. M.; Dimmeler, S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol. 31:2383-2390; 2011.
100. McManus, D. D.; Ambros, V. Circulating microRNAs in cardiovascular disease. Circulation 124:1908-1910; 2011.
101. Sun, X.; Zhang, M.; Sanagawa, A.; Mori, C.; Ito, S.; Iwaki, S., et al. Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb. J 10:16; 2012.
102. Kosaka, N.; Iguchi, H.; Yoshioka, Y.; Takeshita, F.; Matsuki, Y.; Ochiya, T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285:17442-17452; 2010.
103. Zhang, Y.; Liu, D.; Chen, X.; Li, J.; Li, L.; Bian, Z., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39:133-144; 2010.
104. Zhou, J.; Li, J. Y.; Nguyen, P.; Wang, K. C.; Weiss, A.; Kuo, Y. C., et al. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted micro-RNA-126: role of shear stress. Circ. Res. 113: 40-51; 2013.
105. Hergenreider, E.; Heydt, S.; Treguer, K.; Boettger, T.; Horrevoets, A. J.; Zeiher, A. M., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14:249-256; 2012.